BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6580489)

  • 1. Immunodiagnosis of colorectal cancer: clinical evaluation of Tennessee antigen (Tenagen).
    Dent OF; Chapuis PH; Payne JE; Meyer J; Sutherland AM; Goulston KJ
    J Natl Cancer Inst; 1983 Nov; 71(5):893-6. PubMed ID: 6580489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Carcinoembryonic antigen. Evaluation in intestinal lavage fluids and in the tissue of colorectal tumors].
    Beaudonnet A; Guillaud M; Pichot J; Revenant MC; Evreux M
    Ann Gastroenterol Hepatol (Paris); 1986; 22(4):223-5. PubMed ID: 3530109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostaining of carcinoembryonic antigen in colorectal adenocarcinomas and polyps.
    Lascano EF; Patitó JA; Salama AA; Garriz R
    Medicina (B Aires); 1979; 39(3):369-74. PubMed ID: 390298
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tennessee antigen: its value in the monitoring of patients with colorectal cancer.
    Gray BN; Walker C; Barnard R; Bennett RC
    Dis Colon Rectum; 1982 Sep; 25(6):542-4. PubMed ID: 7117058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue carcinoembryonic antigen, dysplasia, and disease duration in colonic inflammatory bowel disease.
    Greenstein AJ; Panvelliwalla DK; Katz LB; Heimann TM; Donnelly J; Pertsimlidis D; Geller S; Smith H; Aufses AH
    Am J Gastroenterol; 1982 Apr; 77(4):212-5. PubMed ID: 7072691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preoperative determination of carcinoembryonic antigen and gastrointestinal antigen in neoplastic colorectal pathology. Case contributions].
    Ramella A; Bussone R; Sanlorenzo M; Natta F; Caldarola B; Schirripa C; Giani R; Pecchio F; Rocca N
    Minerva Chir; 1987 Jun; 42(12):1037-43. PubMed ID: 3476864
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of serum tissue polypeptide antigen (TPA) in patients with colo-rectal cancer].
    Yukawa H; Kono N; Taniguchi K; Ieda K; Ono K; Yamamoto S; Koh K; Ohta M; Hayashido M; Yamaguchi K
    Nihon Geka Hokan; 1984 Mar; 53(2):433-6. PubMed ID: 6508467
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitumor immune response to colorectal cancer antigen detected by the leukocyte adherence inhibition test (LAI) in groups at high risk for colorectal cancer.
    Shani A; Fink A; Bass D; Gottesfeld F; Becker S; Levy E; Bentwich Z; Rozen P; Fireman Z; Hallak A
    Cancer Detect Prev; 1986; 9(5-6):485-90. PubMed ID: 3779710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen in patients with colorectal cancer: correlation between stage of disease and antigen level.
    Bartal AH; Ayalon D; Cordova T; Avidan S; Robinson E
    Isr J Med Sci; 1983 Sep; 19(9):801-5. PubMed ID: 6643017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of LewisX and sialylated LewisX antigens in human colorectal polyps.
    Yuan M; Itzkowitz SH; Ferrell LD; Fukushi Y; Palekar A; Hakomori S; Kim YS
    J Natl Cancer Inst; 1987 Mar; 78(3):479-88. PubMed ID: 3469462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen in hereditary adenomatosis of the colon and rectum.
    Alm T; Wahren B
    Scand J Gastroenterol; 1975; 10(8):875-9. PubMed ID: 1202622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodiagnosis and gastrointestinal cancer.
    Laurence DJ; Turberville C; Leese C; Darcy D; Bettelheim R; Johns EW; Alexander P; Symington T; Neville AM
    Proc R Soc Med; 1972 Nov; 65(11):968-9. PubMed ID: 4642027
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical applications of the carcinoembryonic antigen (CEA) determination in colorectal cancer (observations of 119 cases)].
    Sivelli R; Farinon AM; Chiampo L
    Chir Ital; 1980 Oct; 32(5):946-63. PubMed ID: 6166402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoreactivity in colorectal cancer. Approaches for an immunologic diagnosis?].
    Muhrer KH; Kahle M; Pasurka B
    Schweiz Med Wochenschr; 1983 Apr; 113(15):546-7. PubMed ID: 6857208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum CEA levels in gastrointestinal diseases.
    Miwa M; Senoue I; Watanabe H; Nomiyama T; Suzuki S; Harasawa S; Tani N; Miwa T; Mitomi T; Hata J
    Tokai J Exp Clin Med; 1980 Apr; 5(2):151-3. PubMed ID: 7414628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent progress in tumor markers of the digestive system].
    Mori T
    Gan No Rinsho; 1983 May; 29(6):663-71. PubMed ID: 6876437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The demonstration of carcinoembryonic antigen in colorectal carcinoma and colonic polyps using an immunoperoxidase technique.
    Isaacson P; Le Vann HP
    Cancer; 1976 Sep; 38(3):1348-56. PubMed ID: 782689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
    Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
    J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
    [No Abstract]   [Full Text] [Related]  

  • 20. Localization of carcinoembryogenic antigen (CEA) in normal, inflammatory and neoplastic colonic mucosa by immunofluorescence.
    Gallo V; Golferini A; Capussotti R; Gubetta L; Rizzetto M; Tassi GC
    Boll Ist Sieroter Milan; 1977 Mar; 56(2):132-5. PubMed ID: 326270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.